Disease course and surgery rates in inflammatory bowel disease: A population-based, 7-year follow-up study in the era of immunomodulating therapy

American Journal of Gastroenterology

Volumn 109, Issue 5, 2014, Pages 705-714

  Vester Andersen, Marianne K ^a   Prosberg, Michelle V ^a   Jess, Tine ^b   Andersson, Mikael ^b   Bengtsson, Bo G ^a   Blixt, Thomas ^a   Munkholm, Pia ^a   Bendtsen, Flemming ^a   Vind, Ida ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Department of Epidemiological Research National Health Surveillance and Research   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; BIOLOGICAL THERAPY; CAPSULE ENDOSCOPY; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; COLITIS; COLON RESECTION; COMORBIDITY; CROHN DISEASE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MORTALITY; PANCOLITIS; PNEUMONIA; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; SEPSIS; SKIN CANCER; ULCERATIVE COLITIS; UTERINE CERVIX CARCINOMA IN SITU;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD; CHILD, PRESCHOOL; COLECTOMY; DATABASES, FACTUAL; DENMARK; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899907895     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.45     Document Type: Article

References (37)

1. Ananthakrishnan AN, Weber LR, Knox JF et al. Permanent work disability in Crohn's disease. Am J Gastroenterol 2008; 103: 154-61.
2. Langholz E, Munkholm P, Davidsen M et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11.
3. Munkholm P, Langholz E, Davidsen M et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995; 30: 699-706.
4. Gollop JH, Phillips SF, Melton LJ III et al. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988; 29: 49-56.
5. Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Acta Chir Scand Suppl 1979; 490: 1-84.
6. Moum B, Vatn MH, Ekbom A et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996; 31: 362-6.
7. Solberg IC, Vatn MH, Høie O et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007; 5: 1430-8.
8. Shivananda S, Lennard-Jones J, Logan R et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-7.
9. Vind I, Riis L, Jess T et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006; 101: 1274-82.
10. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39: 30-3.
11. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011; 39: 26-9.
12. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39: 42-5.
13. Munkholm P. Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997; 44: 287-302.
14. Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull 1999; 46: 400-15.
15. Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15.
16. Munkholm P, Langholz E, Nielsen OH et al. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992; 27: 609-14.
17. Louis E, Collard A, Oger AF et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-82.
18. Tarrant KM, Barclay ML, Frampton CMA et al. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008; 103: 3082-93.
19. Henriksen M, Jahnsen J, Lygren I et al. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol 2007; 42: 602-10.
20. Grand DJ, Harris A, Loftus EV. Imaging for luminal disease and complications: CT enterography, MR enterography, small-bowel follow-through, and ultrasound. Gastroenterol Clin North Am 2012; 41: 497-512.
21. Jensen MD, Nathan T, Kjeldsen J. Inter-observer agreement for detection of small bowel Crohn's disease with capsule endoscopy. Scand J Gastroenterol 2010; 45: 878-84.
22. Schwartz DA, Loftus E V, Tremaine WJ et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002; 122: 875-80.
23. Cosnes J, Cattan S, Blain A et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-50.
24. Moum B, Vatn MH, Ekbom A et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol 1996; 31: 355-61.
25. Munkholm P, Langholz E, Davidsen M et al. Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 1994; 35: 360-2.
26. Jess T, Riis L, Vind I et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007; 13: 481-9.
27. Burisch J, Pedersen N, Cukovic-Cavka S et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014; 64: 588-97.
28. Lakatos PL, Golovics PA, David G et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. Am J Gastroenterol 2012; 107: 579-88.
29. Ramadas A V, Gunesh S, Thomas GAO et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010; 59: 1200-6.
30. Nguyen GC, Nugent Z, Shaw S et al. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology 2011; 141: 90-7.
31. Langholz E, Munkholm P, Davidsen M et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-6.
32. Solberg IC, Lygren I, Jahnsen J et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009; 44: 431-40.
33. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993; 38: 1137-46.
34. Williet N, Pillot C, Oussalah A et al. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics. Inflamm Bowel Dis 2012; 18: 1641-6.
35. Hoie O, Wolters FL, Riis L et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007; 132: 507-15.
36. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31: 329-33.
37. Riis L, Munkholm P, Binder V et al. Intra-and interobserver variation in the use of the Vienna classification of Crohn's disease. Inflamm Bowel Dis 2005; 11: 657-61.